Modulate Therapeutics Overview

  • Founded
  • 2015
Founded
  • Status
  • Private
  • Latest Deal Type
  • Series A
  • Investors
  • 2

Modulate Therapeutics General Information

Description

Developer of therapeutics drugs designed to treat neoplastic diseases. The company's drugs increase the presence of tumor-infiltrating lymphocytes while blocking a key mediator of immunosuppression in the tumor micro-environment for patients suffering from different cancer indications, enabling healthcare providers to improve the lives of the cancer patients.

Contact Information

Ownership Status
Privately Held (backing)
Financing Status
Venture Capital-Backed
Primary Industry
Drug Discovery
Other Industries
Pharmaceuticals
Biotechnology
Primary Office
  • Montreal, Quebec
  • Canada
Want detailed data on 3M+ companies?

What you see here scratches the surface

Request a free trial
Want to dig into this profile?

We’ll help you find what you need

Learn more

Modulate Therapeutics Valuation & Funding

Deal Type Date Amount Raised to Date Post-Val Status Stage
2. Early Stage VC (Series A) 01-Feb-2016 Completed Generating Revenue
1. Joint Venture Completed Startup
To view Modulate Therapeutics’s complete valuation and funding history, request access »

Modulate Therapeutics Executive Team (3)

Name Title Board Seat Contact Info
Brian Horsburgh Ph.D Chief Executive Officer, President and Board Member
Mark Cipriano Chief Financial Officer, Consultant & Board Member
Luc Marengère Ph.D Managing Partner & Board Member
To view Modulate Therapeutics’s complete executive team members history, request access »

Modulate Therapeutics Board Members (3)

Name Representing Role Since
Helen Delahaye Modulate Therapeutics Board Member 000 0000
Luc Marengère Ph.D Modulate Therapeutics Managing Partner & Board Member 000 0000
Mark Cipriano Modulate Therapeutics Chief Financial Officer, Consultant & Board Member 000 0000
To view Modulate Therapeutics’s complete board members history, request access »

Modulate Therapeutics Investors (2)

Investor Name Investor Type Holding Investor Since Participating Rounds Contact Info
TVM Capital Life Science Venture Capital Majority 000 0000 000000 0
Immunova Corporation Majority 000 0000 000000 0
To view Modulate Therapeutics’s complete investors history, request access »